Article
The potential of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide to circumvent three multidrug-resistance phenotypes in vitro.
Cancer chemotherapy and pharmacology - 1 Jan 1997
Davey R A, Su G M, Hargrave R M, Harvie R M, Baguley B C, Davey M W
Abstract excerpt
The effectiveness of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) relative to that of amsacrine, idarubicin, daunorubicin and paclitaxel against three different forms of multidrug resistance (MDR) was determined using two sublines of the CCRF-CEM human leukaemia cell line, the P-glyco-protein-expressing CEM/VLB100 subline and the MRP-expressing CEM/E1000 subline, and two extended-MDR sublines of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
